sigma-peptides_Tirzepatide_5mg-1024x1024
Weight Loss
sigma-peptides_Tirzepatide_5mg-1024x1024
Weight Loss

Tirzepatide

Tirzepatide is a prescription medication used for weight loss and long-term weight management by targeting hormones that regulate appetite, food intake, and blood sugar control.
Tirzepatide, sold under the brand name Mounjaro, is a dual GLP-1 and GIP receptor agonist that enhances feelings of fullness, reduces hunger, and improves blood sugar control.
Tirzepatide is FDA-approved for type 2 diabetes management and is being studied for weight loss in individuals with obesity or overweight.
Patients often see weight loss results within a few weeks of starting Tirzepatide, with substantial results after 16–20 weeks.
This treatment is prescribed for adults who are overweight or obese, especially those with weight-related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol. It is administered as a once-weekly injection along with lifestyle changes. See pricing details here.

Real patients, real results

How effective is Tirzepatide

Clinically proven results

Substantial weight loss and appetite control with consistent weekly treatment.*
Clinical trials show that Tirzepatide can lead to significant reductions in body weight, helping many patients achieve and maintain long-term improvements.
*Many individuals achieved 15–22% average weight loss within 12–18 months when combined with healthy diet and exercise.
Tirzepatide should be used only as prescribed by a healthcare provider. For more information, see Important Safety Information.

How DermOnDemand Works

Common Question

Side effects include nausea, diarrhea, constipation, and decreased appetite. These symptoms are usually mild and improve with continued use.

Tirzepatide is currently FDA-approved for diabetes but is not yet officially approved for weight
loss. However, it is often prescribed off-label for this purpose.

While not FDA-approved for weight loss yet, Tirzepatide is being studied as a treatment for obesity in non-diabetic individuals. Discuss this option with your doctor.
Yes, combining Tirzepatide with a balanced diet and regular exercise enhances weight loss outcomes.
If you miss a dose, take it as soon as possible within 4 days. If more than 4 days have passed, skip the missed dose and resume your regular schedule.
Long-term side effects are rare but may include gallbladder issues or pancreatitis. Regular check- ups can help monitor for potential complications.
Tirzepatide targets both GLP-1 and GIP hormones, offering dual benefits for appetite suppression and metabolic regulation, whereas semaglutide targets only GLP-1.